Skip to main content
. 2021 Feb 9;34(6):642–652. doi: 10.1016/j.echo.2021.02.003

Table 1.

Baseline characteristics (n = 200)

Variable Value
Age, y 64.2 ± 19.2
Gender, male 121 (60.5)
Body surface area, m2 2.1 ± 1.9
Ischemic heart disease 30 (15)
Congestive heart failure 22 (11)
Status post coronary artery bypass graft 10 (5)
Atrial fibrillation/flutter 34 (17)
Transient ischemic attack/stroke 21 (10.5)
Chronic obstructive pulmonary disease 13 (6.5)
Diabetes mellitus 57 (28.5)
Hypertension 109 (54.5)
Obesity 49 (24.5)
Chronic medications
 Direct oral anticoagulant 28 (14)
 Angiotensin-converting enzyme inhibitor 40 (20)
 Angiotensin receptor blocker 26 (13)
 β-blocker 52 (26)
 Systemic corticosteroid 10 (5)
Laboratory values on admission
 Hemoglobin, g/dL 13.1 ± 2
 Lymphocytes, 103/μL 1.2 ± 0.7
 Creatinine, mg/dL 0.89 (0.73–1.22)
 Blood urea nitrogen, mg/dL 23.9 ± 19.6
 C-reactive protein, mg/L 72.3 ± 71.1
 Troponin I, ng/L 9 (4–21.5)
 Troponin I > 28 ng/L 36 (19)
 BNP, pg/mL 45 (18–141)
 BNP > 80 pg/mL 56 (31)
 d-dimer, mg/L 1.66 ± 1.5
 d-dimer > 0.5 mg/L 138 (72)
Physical examination on admission
 Lung crackles 28 (19)
 Heart rate, beats/min 85 ± 17
 Systolic blood pressure, mm Hg 134 ± 22
 Diastolic blood pressure, mm Hg 73 ± 15
 O2 saturation, % 95 (90–98)
 Temperature, °C 37.1 (36.7–37.9)
Chest radiographic findings on admission
 Lobar infiltration 31 (16)
 Bilateral infiltration 76 (39)
 Pleural effusion 25 (13)
Clinical assessment scores on admission
 SOFA score 1 (0–3)
 MEWS 4 (2–6)

Data are expressed as mean ± SD, number (percentage), or median (interquartile range).

BNP, Brain natriuretic peptide.